TPIA
Mycotopia Therapies Inc. [TPIA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TPIA Stock Summary
In the News
TPIA Financial details
Company Rating
-
Market Cap
1.49M
Income
-2.28M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
31 Dec 2022
P/E
-0.1
Forward P/E
-
PEG
0.03
P/S
-
P/B
-0.14
P/C
-
P/FCF
-1.92
Quick Ratio
0.15
Current Ratio
0.15
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.15
EPS next Y
-
EPS next Q
-
EPS this Y
13.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
10.7%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-718%
ROE
174%
ROC
0.57%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.01-0.18
52W High
-
52W Low
-
RSI
41
Rel Volume
1.96
Avg Volume
37.71K
Volume
73.92K
Perf Week
-76.28%
Perf Month
-45.56%
Perf Quarter
-
Perf Half Y
11.76%
-
-
-
-
Beta
2.545
-
-
Volatility
0.02%, 0.03%
Prev Close
-75.89%
Price
0.019
Change
-64.81%
Company Profile
- Volume Average 37.71K
- Market Capitalization 1.49M
- Employee 1
- CEO Mr. Benjamin Kaplan
- Headquarters Aventura,FL,US
- IPO Date 2006-03-31
-
Website
https://www.mycotopiatherapies.com 
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
